MYX 3.13% $3.95 mayne pharma group limited

Ann: Mayne Pharma Market Update, page-3

  1. 12,658 Posts.
    lightbulb Created with Sketch. 1332
    It seems that the blowtorch has been applied to Mayne Pharma over the self inflicted confusion on reporting unit sales.

    That guidance has been reaffirmed just 6 weeks from financial year close is a good thing.

    Let’s hope the lesson has been learned here.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.